Shanghai Rongtai Health Technology (SHSE:603579) Cyclically Adjusted Revenue per Share: ¥11.58 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603579 Shanghai Rongtai Health Technology Corp Ltd SHSE:603579
70 GF Score
Price ¥18.03
GF Value ¥17.46
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Shanghai Rongtai Health Technology Cyclically Adjusted Revenue per Share?

Shanghai Rongtai Health Technology SHSE:603579 +0.33% 70 Cyclically Adjusted Revenue per Share is ¥11.58 as of Jun. 2026. GuruFocus rates SHSE:603579 with a GF Score™ of 70/100 and a GF Value™ of ¥17.46 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Shanghai Rongtai Health Technology's adjusted revenue per share for the three months ended in Jun. 2026 was ¥2.723. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥11.58 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Shanghai Rongtai Health Technology's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-22), Shanghai Rongtai Health Technology's current stock price is ¥18.03. Shanghai Rongtai Health Technology's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ¥11.58. Shanghai Rongtai Health Technology's Cyclically Adjusted PS Ratio of today is 1.56.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shanghai Rongtai Health Technology was 3.68. The lowest was 0.95. And the median was 1.88.


Shanghai Rongtai Health Technology  (SHSE:603579) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shanghai Rongtai Health Technology's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=18.03/11.58
=1.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shanghai Rongtai Health Technology was 3.68. The lowest was 0.95. And the median was 1.88.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Shanghai Rongtai Health Technology Cyclically Adjusted Revenue per Share Related Terms


Shanghai Rongtai Health Technology Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Shanghai Rongtai Health Technology's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Rongtai Health Technology Cyclically Adjusted Revenue per Share Chart

Shanghai Rongtai Health Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 11.78 11.56

Shanghai Rongtai Health Technology Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.65 11.60 11.56 11.60 11.58

SHSE:603579 vs AS, HAS, LTH: Cyclically Adjusted Revenue per Share Comparison

For the Leisure subindustry, Shanghai Rongtai Health Technology's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Rongtai Health Technology Cyclically Adjusted PS Ratio vs Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Shanghai Rongtai Health Technology's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Rongtai Health Technology's Cyclically Adjusted PS Ratio falls into.


SHSE:603579
70GF Score
Shanghai Rongtai Health Technology Corp Ltd SHSE:603579
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Rongtai Health Technology Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanghai Rongtai Health Technology's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.723/116.0564*116.0564
=2.723

Current CPI (Jun. 2026) = 116.0564.

Shanghai Rongtai Health Technology Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1.941 102.400 2.200
201612 3.191 102.600 3.610
201703 2.202 103.200 2.476
201706 2.499 103.100 2.813
201709 2.532 104.100 2.823
201712 3.730 104.500 4.142
201803 3.344 105.300 3.686
201806 3.449 104.900 3.816
201809 2.861 106.600 3.115
201812 2.974 106.500 3.241
201903 2.791 107.700 3.008
201906 3.252 107.700 3.504
201909 2.938 109.800 3.105
201912 3.839 111.200 4.007
202003 1.865 112.300 1.927
202006 3.105 110.400 3.264
202009 2.968 111.700 3.084
202012 3.425 111.500 3.565
202103 2.799 112.662 2.883
202106 4.066 111.769 4.222
202109 3.279 112.215 3.391
202112 4.292 113.108 4.404
202203 3.128 114.335 3.175
202206 3.099 114.558 3.140
202209 2.620 115.339 2.636
202212 2.560 115.116 2.581
202303 2.215 115.116 2.233
202306 2.871 114.558 2.909
202309 1.802 115.339 1.813
202312 3.280 114.781 3.316
202403 2.107 115.227 2.122
202406 2.189 114.781 2.213
202409 1.617 115.785 1.621
202412 2.188 114.893 2.210
202503 2.157 115.116 2.175
202506 2.406 114.907 2.430
202509 1.884 115.471 1.894
202512 2.139 115.832 2.143
202603 2.219 116.303 2.214
202606 2.723 116.056 2.723

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ¥11.58 mean?
Shanghai Rongtai Health Technology (SHSE:603579) has a Cyclically Adjusted Revenue per Share of ¥11.58 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shanghai Rongtai Health Technology and its competitors.
Is Shanghai Rongtai Health Technology's Cyclically Adjusted Revenue per Share too high?
Shanghai Rongtai Health Technology's current Cyclically Adjusted Revenue per Share is ¥11.58. Overall, Shanghai Rongtai Health Technology has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Rongtai Health Technology's Cyclically Adjusted Revenue per Share compare to AS and HAS?
Shanghai Rongtai Health Technology's Cyclically Adjusted Revenue per Share of ¥11.58 can be compared against companies in the Travel & Leisure industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Travel & Leisure company?
A good Cyclically Adjusted Revenue per Share depends on the Travel & Leisure industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shanghai Rongtai Health Technology and its competitors. Shanghai Rongtai Health Technology's current Cyclically Adjusted Revenue per Share is ¥11.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Rongtai Health Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology (SHSE:603579) is currently considered Fairly Valued. The stock's GF Value™ is ¥17.46, compared to a current price of ¥18.03 — trading 3.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ¥11.58. Shanghai Rongtai Health Technology's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Shanghai Rongtai Health Technology (SHSE:603579), the current Cyclically Adjusted Revenue per Share is ¥11.58 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Rongtai Health Technology (SHSE:603579) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Rongtai Health Technology stock appears to be overvalued. The current stock price of ¥18.03 is trading 3.3% above its estimated GF Value™ of ¥17.46. GuruFocus considers Shanghai Rongtai Health Technology to be Fairly Valued.

Key valuation signals for SHSE:603579:

  • Cyclically Adjusted Revenue per Share: ¥11.58
  • GF Value™: ¥17.46 vs. price of ¥18.03 (3.3% above fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603579 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Rongtai Health Technology Business Description

Address No. 1226 ZhuFeng Road, Qingpu District, Shanghai, CHN, 201702
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
70GF Score

Get the complete analysis for SHSE:603579

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.03
Price
¥17.46
GF Value